AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Simon, I Snow, PB Marks, LS Christens-Barry, WA Epstein, JI Bluemke, DA
Citation: I. Simon et al., Neural network prediction of prostate tissue composition based on magneticresonance imaging analysis: A pilot study (vol 22, pg 445, 2000), ANAL QUAN C, 23(2), 2001, pp. 150-150

Authors: Marks, LS Hess, DL Dorey, FJ Macairan, ML Santos, PBC Tyler, VE
Citation: Ls. Marks et al., Tissue effects of saw palmetto and finasteride: Use of biopsy cores for insitu quantification of prostatic androgens, UROLOGY, 57(5), 2001, pp. 999-1005

Authors: Partin, AW Marks, LS
Citation: Aw. Partin et Ls. Marks, Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agents, UROLOGY, 57(4A), 2001, pp. 132-136

Authors: Marks, LS Epstein, JI Partin, AW
Citation: Ls. Marks et al., The role of prostate needle biopsy in evaluation of chemopreventive agents, UROLOGY, 57(4A), 2001, pp. 191-193

Authors: Simon, I Snow, PB Marks, LS Christens-Barry, WA Epstein, JI Bluemke, DA Partin, AW
Citation: I. Simon et al., Neural network prediction of prostate tissue composition eased on magneticresonance imaging analysis - A pilot study, ANAL QUAN C, 22(6), 2000, pp. 445-452

Authors: Mikolajczyk, SD Millar, LS Marker, KM Wang, TJ Rittenhouse, HG Marks, LS Slawin, KM
Citation: Sd. Mikolajczyk et al., Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia, PROSTATE, 45(3), 2000, pp. 271-276

Authors: Marks, LS
Citation: Ls. Marks, Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia? Editorial comment, UROLOGY, 56(2), 2000, pp. 266-266

Authors: Mikolajczyk, SD Millar, LS Wang, TJ Rittenhouse, HG Wolfert, RL Marks, LS Song, WT Wheeler, TM Slawin, KM
Citation: Sd. Mikolajczyk et al., "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia, UROLOGY, 55(1), 2000, pp. 41-45

Authors: Marks, LS Partin, AW Epstein, JI Tyler, VE Simon, I Macairan, ML Chan, TL Dorey, FJ Garris, JB Veltri, RW Santos, PBC Stonebrook, KA deKernion, JB
Citation: Ls. Marks et al., Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia, J UROL, 163(5), 2000, pp. 1451-1456

Authors: Mikolajczyk, SD Millar, LS Wang, TJ Rittenhouse, HG Marks, LS Song, WT Wheeler, TM Slawin, KM
Citation: Sd. Mikolajczyk et al., A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue, CANCER RES, 60(3), 2000, pp. 756-759

Authors: Marks, LS
Citation: Ls. Marks, Transrectal ultrasound with separate measurement of the transition zone volume predicts the short-term outcome after transurethral resection of the prostate - Comment, UROLOGY, 53(5), 1999, pp. 930-930

Authors: Marks, LS
Citation: Ls. Marks, Treatment of erectile dysfunction with sildenafil - Reply, UROLOGY, 53(5), 1999, pp. 1070-1071

Authors: Marks, LS Tyler, VE
Citation: Ls. Marks et Ve. Tyler, Saw palmetto extract: Newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia, UROLOGY, 53(3), 1999, pp. 457-461

Authors: Marks, LS Partin, AW Dorey, FJ Gormley, GJ Epstein, JI Garris, JB Macairan, ML Shery, ED Santos, PB Stoner, E deKernion, JB
Citation: Ls. Marks et al., Long-term effects of finasteride on prostate tissue composition, UROLOGY, 53(3), 1999, pp. 574-580

Authors: Marks, LS Duda, C Dorey, FJ Macairan, ML Santos, PB
Citation: Ls. Marks et al., Treatment of erectile dysfunction with sildenafil, UROLOGY, 53(1), 1999, pp. 19-24

Authors: Mikolajczyk, SD Millar, LS Marker, KM Rittenhouse, HG Wolfert, RL Marks, LS Charlesworth, MC Tindall, DJ
Citation: Sd. Mikolajczyk et al., Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue, CANCER RES, 59(16), 1999, pp. 3927-3930
Risultati: 1-16 |